Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)

Makoto Tahara, N. Kiyota, T. Yokota, Y. Hasegawa, K. Muro, S. Takahashi, T. Onoe, A. Homma, J. Taguchi, M. Suzuki, K. Minato, K. Yane, S. Ueda, H. Hara, K. Saijo, T. Yamanaka

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)'. Together they form a unique fingerprint.

Medicine & Life Sciences